InvestorsHub Logo
Followers 43
Posts 2488
Boards Moderated 0
Alias Born 10/19/2015

Re: La Flaca post# 324666

Thursday, 08/05/2021 3:32:59 PM

Thursday, August 05, 2021 3:32:59 PM

Post# of 463627
Agreed. Usually the system works well. The FAA is another example. But every now and then the system doesn't work because the FDA isn't a machine. It's run by humans, who all have opinions and motivations and every now and then, buckle to pressure from bigger fish.

That's how Aducanumab got approved in the first place, right? It certainly wasn't approved on objectivity. It was the one that slipped through the cracks. I'd be willing to bet the farm that if Anavex had been the company to develop Aducanumab, there's zero chance the drug gets approved on that data.

Like it or not, Biogen has power. That's all I'm saying. It seems likely it'll do everything it can to flex that power to keep its new drug on the market for as long as possible. And I'd be willing to bet my other farm that if Dr. Missling created a SWOT board, Biogen would be listed under "Threats." And maybe "Opportunity" because if Aducanumab were even halfway decent, the FDA would be under no pressure to approve another Alzheimer's drug immediately.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News